Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Katherine Wilemon
Lomitapide approved to treat rare lipid disease in children
Ask a clinical question and tap into Healio AI's knowledge base. • Lomitapide was approved for treatment of homozygous familial hypercholesterolemia in children as young as 2 years. • The drug is designed to be taken alongside diet, exercise and other LDL-lowering therapies. Chiesi Global Rare Diseases announced the FDA approved lomitapide capsules for treatment of homozygous familial hypercholesterolemia in children aged 2 years and older.
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents US Preventive Services Task Force USPSTF Recommendation: Screening for Lipid Disorders in Children and Adolescents US Preventive Services Task Force; Michael J. Barry, MD; Wanda K. Nicholson, MD, MPH, MBA; Michael Silverstein, MD, MPH; David Chelmow, MD; Tumaini Rucker Coker, MD, MBA; Esa M. Davis, MD, MPH; Katrina E.
Familial Hypercholesterolemia -- Hiding in Plain Sight
This transcript has been edited for clarity. Laurence Sperling, MD: Welcome to the Medscape InDiscussion podcast series on dyslipidemia. This is the first of six episodes. To launch this series today, we will focus on an extremely important topic: living with hypercholesterolemia and listening for clues of genetic risk. This topic is central to this series. First, a case presentation.
FDA approves evinacumab for homozygous FH
February 11, 2021 1 min read Save Source/Disclosures Published by: Disclosures: Rader reports he was an investigator for a trial sponsored by Regeneron and is an unpaid consultant to the FH Foundation. Wilemon is an employee of the FH Foundation. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later.
Global consortium issues call to action on familial hypercholesterolemia
A global consortium of representatives from more than 40 countries issued a call to action to address gaps in screening and guideline-based care for patients with familial hypercholesterolemia. The document, published in JAMA Cardiology, includes nine public policy recommendations developed during two meetings.
Familial Hypercholesterolemia: Shining Light on a Serious Genetic Condition
At age 38, I was sent home from the ER despite having a heart attack. I was gardening when I felt crushing chest pain. I called 911 in a panic. When the paramedics arrived, they quickly "ruled out" a heart attack based on my young age, petite build and overall health. I would later learn that women in the throes of a heart attack are often misdiagnosed just as I was.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Katherine
Contact Katherine, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack